Cases 1 - 4 of 4
In Re: BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation
as 2:2014md02510
Counter Defendant:
Invitae Corporation, Myriad Genetics, Quest Diagnostics and others
Counter Claimant:
Pathway Genomics and Ambry Genetics
Undetermined:
Labroratory Corporation of America Holdings, AARP, GeneDX and others
In Re:
BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation
Cause Of Action: 35 U.S.C. § 0271
ASSOCIATION FOR MOLECULAR V PTO
as 10-1406
Amicus Curiae:
AARP, Alliance for Humane Biotechnology, Alnylam Pharmaceuticals, Inc. and others
Defendant-Appellant:
Arnold B. Combe, Director, University of Utah Research Foundation, David W. Pershing, Director, University of Utah Research Foundation, Jack Brittain, Director, University of Utah Research Foundation and others
Plaintiff-Appellee:
Arupa Ganguly, PhD, Boston Women's Health Book Collective, Breast Cancer Action and others
Association For Molecular Pathology et al v. United States Patent and Trademark Office et al
as 1:2009cv04515
Plaintiff:
Association For Molecular Pathology, Association For Molecular Pathology, Association For Molecular Pathology and others
Defendant:
United States Patent and Trademark Office, Myriad Genetics, Lorris Betz and others
Cause Of Action: 28 U.S.C. § 2201 Declaratory Judgement
PROMETHEUS LAB V MAYO COLLABORATIVE
as 08-1403
Amicus Curiae:
ARUP Laboratories, Inc., American Intellectual Property Law Association, Biotechnology Industry Organization and others
Defendant-Appellee:
Mayo Clinic Rochester and Mayo Collaborative Services (dba Mayo Medical Laboratories)
Plaintiff-Appellant:
Prometheus Laboratories, Inc.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
